1) Busui Shengxue Ⅰ
补髓生血Ⅰ号
2) Danggui Buxue Tang Ⅰ
当归补血汤Ⅰ号
1.
Effect of the Danggui Buxue Tang Ⅰin preoperative bronchial artery infusion chemotherapy for non-small-cell lung cancer;
当归补血汤Ⅰ号在非小细胞肺癌术前BAI化疗中的作用
3) Busui Shengxue Granules
补髓生血颗粒
1.
Determination of Lcariin(C_(33)H_(40)O_(15))in Busui Shengxue Granules by RP-HPLC;
RP-HPLC法测定补髓生血颗粒中淫羊藿苷(C_(33)H_(40)O_(15))的含量
2.
To observe the effects and the mechanism of Busui Shengxue granules(补髓生血冲剂)to Chronic Aplastic Anemia(CAA).
目的:探讨补髓生血颗粒对慢性再生障碍性贫血(CAA)患者CD34+细胞及CD34+C-myc细胞表达影响及疗效机理。
4) Soluble granules of Bu Sui Sheng xue
补髓生血冲剂
1.
The influence of Soluble granules of Bu Sui Sheng xue on IL-1β、IFN-γ、TNF-α expression level of chronic aplastic anemia patients;
补髓生血冲剂对慢性再生障碍性贫血患者造血调控因子表达水平的影响
5) Busui Shengxue Granule
补髓生血颗粒
1.
Effect of Busui Shengxue Granule on Serum Tyrosine Kinase 3 Ligand and Fibronectin in Patients with Chronic Aplastic Anemia;
补髓生血颗粒对慢性再生障碍性贫血患者血清酪氨酸激酶-3配体和纤维连接蛋白的影响
2.
Objective To observe the clinical effect of Busui Shengxue granule (BSSXG) in treating chronic aplastic anemia (CAA) and study its mechanism.
目的 观察补髓生血颗粒治疗慢性再生障碍性贫血(CAA)的临床疗效并探讨其作用机理。
3.
Objective: To observe the clinical effect of Busui Shengxue granule(BSSXG) in treating Myelodyplastic Syndrome-Refractory Anemia(MDS-RA),evaluate the expression of the blood IL-10 before and after treatment, and reveal the pathogenesis of MDS-RA and effect mecheanism of supplement BSSXG on MDS-RA.
目的:观察补髓生血颗粒治疗骨髓增生异常综合征之难治性贫(MDS-RA)的临床疗效,检测患者治疗前后血清IL-10表达的变化,进一步探讨补髓生血颗粒治疗MDS-RA的疗效及对IL-10的影响。
6) Busuishengxue granule
补髓生血颗粒
1.
The Clinical Effect and Experimental Study on Serum TNF-α of Patients with Chronic Aplastic Anemia Treated by Busuishengxue Granule;
补髓生血颗粒治疗慢性再生障碍性贫血的疗效及对患者血清TNF-α水平的影响
2.
The Clinical Effect and Experimental Study on the NF-κB of Signal Transduction with CAA Treated by Busuishengxue Granule;
补髓生血颗粒治疗慢性再障的疗效及对信号转导因子NF-κB的影响
3.
Objective: To observe the clinical effect of chronic aplastic anemia (CAA) treated with Busuishengxue granule (BSSXG) and the difference in expression levels of LFA-3/CD58, CD11b, Ln and IL-12 before and after treatment.
目的:观察补髓生血颗粒对慢性再障(CAA)的临床疗效及对粘附分子LFA-3/CD58、CD11b、Ln和细胞因子IL-12的影响。
补充资料:血髓
1.血液和骨髓。 2.比喻人们耗尽血汗和生命而得到的财富。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条